Millennium Management’s Acadia Pharmaceuticals ACAD Stock Holding History

Millennium Management’s Portfolio ACAD Stock Details ACAD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-51,300	Closed	-$949K	–	5807
2024 Q1	$949K	Buy	+51,300	New	+$1.27M	﹤0.01%	4334
2023 Q4	–	Sell	-384,500	Closed	-$8.01M	–	6010
2023 Q3	$8.01M	Buy	+384,500	New	+$10.4M	﹤0.01%	2265
2022 Q1	–	Sell	-75,000	Closed	-$1.75M	–	6828
2021 Q4	$1.75M	Buy	+75,000	New	+$1.51M	﹤0.01%	3899
2021 Q3	–	Sell	-125,000	Closed	-$3.05M	–	6713
2021 Q2	$3.05M	Buy	125,000 +17,000	+16%	+$384K	﹤0.01%	3415
2021 Q1	$2.79M	Buy	108,000 +8,000	+8%	+$352K	﹤0.01%	3207
2020 Q4	$5.35M	Buy	+100,000	New	+$4.96M	﹤0.01%	2376
2019 Q3	–	Sell	-311,500	Closed	-$8.33M	–	4108
2019 Q2	$8.33M	Buy	+311,500	New	+$7.96M	0.01%	1393
2017 Q1	–	Sell	-175,000	Closed	-$5.05M	–	3441
2016 Q4	$5.05M	Buy	175,000 +165,000	+1,650%	+$4.37M	0.01%	1322
2016 Q3	$318K	Sell	10,000 -40,000	-80%	-$1.36M	﹤0.01%	2789
2016 Q2	$1.62M	Buy	+50,000	New	+$1.67M	﹤0.01%	1900
2015 Q1	–	Sell	-151,800	Closed	-$4.82M	–	3514
2014 Q4	$4.82M	Sell	151,800 -1,100	-0.7%	-$31.2K	0.01%	1417
2014 Q3	$3.79M	Sell	152,900 -2,100	-1%	-$49.1K	0.01%	1455
2014 Q2	$3.5M	Sell	155,000 -3,100	-2%	-$64.7K	0.01%	1422
2014 Q1	$3.85M	Sell	158,100 -116,900	-43%	-$2.96M	0.01%	1353
2013 Q4	$6.87M	Sell	275,000 -113,000	-29%	-$2.67M	0.02%	946
2013 Q3	$10.7M	Buy	388,000 +183,200	+89%	+$3.83M	0.03%	646
2013 Q2	$3.72M	Buy	+204,800	New	+$2.82M	0.01%	1209

Other funds holding ACAD

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Millennium Management's ACAD Position: Q1 2026 in Review

Millennium Management increased its Acadia Pharmaceuticals (ACAD) stake by 27% in Q1 2026, buying an estimated $3.63M and bringing the position to 705,461 shares worth $15.7M. The position accounts for 0.01% of the portfolio, ranked #1750.

Millennium Management first reported a position in ACAD in Q2 2013 and has held it in 50 quarters since. The position peaked at $55.5M in Q4 2016. 340 funds tracked by Wall St. Rank hold ACAD as of Q1 2026.

Millennium Management held 705,461 shares of Acadia Pharmaceuticals worth $15.7M as of Q1 2026.
Millennium Management bought 151,787 Acadia Pharmaceuticals shares in Q1 2026, an estimated $3.63M.
Acadia Pharmaceuticals made up 0.01% of Millennium Management's portfolio in Q1 2026, its #1750 holding.
Millennium Management first reported a position in Acadia Pharmaceuticals in Q2 2013 and has held it in 50 quarters since.
Millennium Management's Acadia Pharmaceuticals position peaked at $55.5M in Q4 2016.
340 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.